Russell Investments Group, Ltd. Apellis Pharmaceuticals, Inc. Transaction History
Russell Investments Group, Ltd.
- $70.2 Billion
- Q1 2025
A detailed history of Russell Investments Group, Ltd. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 38,903 shares of APLS stock, worth $929,781. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,903
Previous 6,107
537.02%
Holding current value
$929,781
Previous $194,000
338.14%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding APLS
# of Institutions
281Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$294 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$292 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$284 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$243 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$230 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.63B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...